Literature DB >> 29543559

Spontaneous Glioblastoma Spheroid Infiltration of Early-Stage Cerebral Organoids Models Brain Tumor Invasion.

Bárbara da Silva1, Ryan K Mathew1,2, Euan S Polson1, Jennifer Williams1, Heiko Wurdak1.   

Abstract

Organoid methodology provides a platform for the ex vivo investigation of the cellular and molecular mechanisms underlying brain development and disease. The high-grade brain tumor glioblastoma multiforme (GBM) is considered a cancer of unmet clinical need, in part due to GBM cell infiltration into healthy brain parenchyma, making complete surgical resection improbable. Modeling the process of GBM invasion in real time is challenging as it requires both tumor and neural tissue compartments. Here, we demonstrate that human GBM spheroids possess the ability to spontaneously infiltrate early-stage cerebral organoids (eCOs). The resulting formation of hybrid organoids demonstrated an invasive tumor phenotype that was distinct from noncancerous adult neural progenitor (NP) spheroid incorporation into eCOs. These findings provide a basis for the modeling and quantification of the GBM infiltration process using a stem-cell-based organoid approach, and may be used for the identification of anti-GBM invasion strategies.

Entities:  

Keywords:  brain tumor cell migration; glioblastoma stem-cell-like cells; hybrid compartment organoids; three-dimensional cellular assay

Mesh:

Substances:

Year:  2018        PMID: 29543559     DOI: 10.1177/2472555218764623

Source DB:  PubMed          Journal:  SLAS Discov        ISSN: 2472-5552            Impact factor:   3.341


  29 in total

1.  CEREBRAL ORGANOIDS AS A MODEL FOR GLIOBLASTOMA MULTIFORME.

Authors:  Nathaniel Silvia; Guohao Dai
Journal:  Curr Opin Biomed Eng       Date:  2020-03-25

Review 2.  Applications of Human Brain Organoids to Clinical Problems.

Authors:  H Isaac Chen; Hongjun Song; Guo-Li Ming
Journal:  Dev Dyn       Date:  2018-10-02       Impact factor: 3.780

Review 3.  Brain organoids as a model system for human neurodevelopment and disease.

Authors:  Harpreet Setia; Alysson R Muotri
Journal:  Semin Cell Dev Biol       Date:  2019-03-23       Impact factor: 7.727

4.  Patient-Derived Tumor Organoids for Guidance of Personalized Drug Therapies in Recurrent Glioblastoma.

Authors:  Miriam Ratliff; Hichul Kim; Hao Qi; Minsung Kim; Bosung Ku; Daniel Dominguez Azorin; David Hausmann; Rajiv K Khajuria; Areeba Patel; Elena Maier; Loic Cousin; Arnaud Ogier; Felix Sahm; Nima Etminan; Lukas Bunse; Frank Winkler; Victoria El-Khoury; Michael Platten; Yong-Jun Kwon
Journal:  Int J Mol Sci       Date:  2022-06-12       Impact factor: 6.208

Review 5.  CNS organoids: an innovative tool for neurological disease modeling and drug neurotoxicity screening.

Authors:  Tanya Chhibber; Sounak Bagchi; Behnaz Lahooti; Angela Verma; Abraham Al-Ahmad; Manash K Paul; Gurudutt Pendyala; Rahul Dev Jayant
Journal:  Drug Discov Today       Date:  2019-11-26       Impact factor: 7.851

6.  A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity.

Authors:  Fadi Jacob; Ryan D Salinas; Daniel Y Zhang; Phuong T T Nguyen; Jordan G Schnoll; Samuel Zheng Hao Wong; Radhika Thokala; Saad Sheikh; Deeksha Saxena; Stefan Prokop; Di-Ao Liu; Xuyu Qian; Dmitriy Petrov; Timothy Lucas; H Isaac Chen; Jay F Dorsey; Kimberly M Christian; Zev A Binder; MacLean Nasrallah; Steven Brem; Donald M O'Rourke; Guo-Li Ming; Hongjun Song
Journal:  Cell       Date:  2019-12-26       Impact factor: 41.582

7.  Outer Radial Glia-like Cancer Stem Cells Contribute to Heterogeneity of Glioblastoma.

Authors:  Aparna Bhaduri; Elizabeth Di Lullo; Diane Jung; Sören Müller; Elizabeth Erin Crouch; Carmen Sandoval Espinosa; Tomoko Ozawa; Beatriz Alvarado; Julien Spatazza; Cathryn René Cadwell; Grace Wilkins; Dmitry Velmeshev; Siyuan John Liu; Martina Malatesta; Madeline Gail Andrews; Mohammed Andres Mostajo-Radji; Eric Jinsheng Huang; Tomasz Jan Nowakowski; Daniel Amos Lim; Aaron Diaz; David Ronan Raleigh; Arnold Richard Kriegstein
Journal:  Cell Stem Cell       Date:  2020-01-02       Impact factor: 24.633

Review 8.  Organoid technology and applications in cancer research.

Authors:  Hanxiao Xu; Xiaodong Lyu; Ming Yi; Weiheng Zhao; Yongping Song; Kongming Wu
Journal:  J Hematol Oncol       Date:  2018-09-15       Impact factor: 17.388

Review 9.  Modeling neurological disorders using brain organoids.

Authors:  Daniel Y Zhang; Hongjun Song; Guo-Li Ming
Journal:  Semin Cell Dev Biol       Date:  2020-06-17       Impact factor: 7.727

Review 10.  Patient-Derived Cancer Organoids for Precision Oncology Treatment.

Authors:  Mark N Pernik; Cylaina E Bird; Jeffrey I Traylor; Diana D Shi; Timothy E Richardson; Samuel K McBrayer; Kalil G Abdullah
Journal:  J Pers Med       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.